盘龙药业：氟比洛芬贴剂获准开展临床试验

Group 1 - The company, Panlong Pharmaceutical (002864.SZ), has received approval from the National Medical Products Administration for the clinical trial of Flurbiprofen transdermal patch [1] - The approved indications for the clinical trial include pain relief and anti-inflammatory treatment for conditions such as osteoarthritis, periarthritis of the shoulder, tendinitis, tenosynovitis, tendinopathy, lateral epicondylitis (e.g., tennis elbow), muscle pain, and swelling and pain after trauma [1]